Gaining Ground: AIM ImmunoTech Inc (AIM) Closes Higher at 0.38, Up 6.49

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The price of AIM ImmunoTech Inc (AMEX: AIM) closed at $0.38 in the last session, up 6.49% from day before closing price of $0.36. In other words, the price has increased by $6.49 from its previous closing price. On the day, 0.18 million shares were traded. AIM stock price reached its highest trading level at $0.389 during the session, while it also had its lowest trading level at $0.3617.


We take a closer look at AIM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.14 and its Current Ratio is at 1.14. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.31.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 06 ’24 when Equels Thomas K bought 61,729 shares for $0.41 per share. The transaction valued at 25,000 led to the insider holds 778,184 shares of the business.

Rodino Peter W III bought 30,865 shares of AIM for $12,500 on May 06 ’24. The COO, Secretary, Gen. Counsel now owns 212,583 shares after completing the transaction at $0.41 per share. On Mar 21 ’24, another insider, BRYAN NANCY, who serves as the Director of the company, bought 38,462 shares for $0.39 each. As a result, the insider paid 15,000 and bolstered with 38,462 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AIM now has a Market Capitalization of 21929066 and an Enterprise Value of 12778816. For the stock, the TTM Price-to-Sale (P/S) ratio is 115.42 while its Price-to-Book (P/B) ratio in mrq is 4.66. Its current Enterprise Value per Revenue stands at 66.211 whereas that against EBITDA is -0.386.

Stock Price History:

The Beta on a monthly basis for AIM is -0.35, which has changed by -0.38709676 over the last 52 weeks, in comparison to a change of 0.25510752 over the same period for the S&P500. Over the past 52 weeks, AIM has reached a high of $0.75, while it has fallen to a 52-week low of $0.31. The 50-Day Moving Average of the stock is -3.79%, while the 200-Day Moving Average is calculated to be -12.94%.

Shares Statistics:

According to the various share statistics, AIM traded on average about 288.25K shares per day over the past 3-months and 196190 shares per day over the past 10 days. A total of 57.14M shares are outstanding, with a floating share count of 52.06M. Insiders hold about 8.88% of the company’s shares, while institutions hold 7.17% stake in the company. Shares short for AIM as of 1718323200 were 509587 with a Short Ratio of 1.77, compared to 1715731200 on 433194. Therefore, it implies a Short% of Shares Outstanding of 509587 and a Short% of Float of 0.91.

Most Popular